Camizestrant |
|
|---|---|
| CAT. No : | C2710000 |
| CAS. No : | 2222844-89-3 |
| Mol. F : | C24H28F4N6 |
| Mol. Wt : | 476.51 g/mol |
| Synonyms : | 3-Pyridinamine,N-[1-(3-fluoropropyl)-3-azetidinyl]-6-[(6S,8R)-6,7,8,9-tetrahydro-8-methyl-7-(2,2,2-trifluoroethyl)-3H-pyrazolo[4,3-f]isoquinolin-6-yl] |
| Chemical Name : | N-(1-(3-Fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine |
| Stock Status : | Custom Synthesis |
- Smiles:FC(F)(F)CN([C@@H]1C)[C@H](C(N=C2)=CC=C2NC(C3)CN3CCCF)C4=C(C1)C(C=NN5)=C5C=C4
- Buy High-Quality Camizestrant Reference Standards, Impurity Standards, Metabolites, Analytical Standards, Pharmacopoeial & Non-Pharmacopoeial Standards from Simson Pharma.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Buy 2222844-89-3 | Purchase 2222844-89-3 | Order 2222844-89-3 | Enquire 2222844-89-3 | Price of 2222844-89-3 | 2222844-89-3 Supplier | 2222844-89-3 Manufacturer | 2222844-89-3 Exporter | Camizestrant for Method Validation | Camizestrant Reference Standard | Camizestrant for ANDA Filing | Camizestrant for Forced Degradation Studies | Camizestrant Identification Standards | Camizestrant for DMF Filing | Buy high quality Camizestrant | Purchase Camizestrant | Camizestrant suppliers | Camizestrant manufacturers | Camizestrant price | Camizestrant exporter | Order Camizestrant | Enquire Camizestrant | Camizestrant cost | Camizestrant Supplier | Camizestrant Distributor
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
